» Articles » PMID: 39192663

Associations Between Severe Influenza-Complicated Thromboembolism Events, Intensive Care Unit Stays and Mortality, and Associated Risk Factors: A Retrospective Cohort Study

Abstract

Methods: A retrospective cohort study was conducted, recruiting consecutive patients with TE events admitted to the ICU between December 2015 through December 2018 at our institution in Taiwan. The study included a group of 108 patients with severe influenza and a control group of 192 patients with severe community-acquired pneumonia. Associations between complicated TE, length of ICU stay, and 90-day mortality were evaluated using logistic regression analysis, and risk factors were identified using univariate and multivariate generalized linear regression analyses.

Results: TE event prevalence was significantly higher in ICU patients with severe influenza than in ICU patients with severe CAP (21.3% vs. 5.7%, respectively; p < 0.05). Patients with severe influenza who developed TE experienced a significant increase in the ratio of mechanical ventilation use, length of mechanical ventilation use, ICU stay, and 90-day mortality when compared to patients without TE (all p < 0.05). The comparison of severe CAP patients with and without TE revealed no significant differences (p > 0.05). The development of thromboembolic events in patients with severe influenza or severe noninfluenza CAP is linked to influenza infection and hypertension (p < 0.05). Furthermore, complicated TE and the severity of the APACHE II score are risk factors for 90-day mortality in ICU patients with severe influenza (p < 0.05).

Conclusions: Patients with severe influenza and complicated TE are more likely to have an extended ICU stay and 90-day mortality than patients with severe CAP. The risk is significantly higher for patients with a higher APACHE II score. The results of this study may aid in defining better strategies for early recognition and prevention of severe influenza-complicated TE.

Citing Articles

Effect of bronchofiberscopic lavage with acetylcysteine instillation on refractory mycoplasma pneumoniae pneumonia in children: a retrospective clinical observation.

Li P, Fu H, Liu K, Li F, Yang J Ital J Pediatr. 2025; 51(1):62.

PMID: 40022245 PMC: 11871767. DOI: 10.1186/s13052-025-01879-y.

References
1.
Levy D, Wilson P, Anderson K, CASTELLI W . Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J. 1990; 119(3 Pt 2):712-7; discussion 717. DOI: 10.1016/s0002-8703(05)80050-x. View

2.
Fislova T, Gocnik M, Sladkova T, Durmanova V, Rajcani J, Vareckova E . Multiorgan distribution of human influenza A virus strains observed in a mouse model. Arch Virol. 2009; 154(3):409-19. DOI: 10.1007/s00705-009-0318-8. View

3.
Wang J, Xu H, Yang X, Zhao D, Liu S, Sun X . Cardiac complications associated with the influenza viruses A subtype H7N9 or pandemic H1N1 in critically ill patients under intensive care. Braz J Infect Dis. 2016; 21(1):12-18. PMC: 9425542. DOI: 10.1016/j.bjid.2016.10.005. View

4.
Kwong J, Schwartz K, Campitelli M, Chung H, Crowcroft N, Karnauchow T . Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med. 2018; 378(4):345-353. DOI: 10.1056/NEJMoa1702090. View

5.
. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4):388-416. DOI: 10.1164/rccm.200405-644ST. View